Breakthroughs for Innovative Products Going Overseas with Global Operation Capabilities Continuing to Strengthen SHANGHAI, Aug. 28, 2024 /PRNewswire/ — On August 27, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or “the Group”; Stock Code: 600196.SH; 02196.HK),…
Month: August 2024
Harbour BioMed Announces 2024 Interim Results
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ — Harbour BioMed (“HBM”, or the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on…
Bitrue Joins Hands With CV Pad to Bring New Web3 Projects to Fruition
VICTORIA, Seychelles, Aug. 28, 2024 /PRNewswire/ — Bitrue, one of the most well-established cryptocurrency exchanges with over 6 years of operations, has partnered with cryptocurrency incubator CV Pad in order to grow the web3 industry. CV Pad is one of the most influential incubators in…
Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization
“Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®” “While maintaining the current process for emergency use authorization for mild-to-moderate COVID-19 patients, Hyundai Bioscience will expedite Phase 3 clinical…
DPC Dash Ltd Announces 2024 Interim Financial Results
Revenues increased to RMB2.04 billion, representing 48.3% year-over-year growth Adjusted net profit reached RMB50.9 million, from an adjusted net loss of RMB17.4 million in the same period of 2023 Store-level operating profit grew by 59.0%; Adjusted group EBITDA increased by 83.7% Added…
LIAN Group baut seine Gesundheitsplattform mit der strategischen Akquisition von Scientis aus, dem von Dermatologen empfohlenen Produkt für Hyperpigmentierung
GENF, 28. August 2024 /PRNewswire/ — Als Teil ihrer Gesundheitsplattform gibt die LIAN Gruppe die Übernahme von Scientis bekannt, einem innovativen Schweizer Unternehmen für kosmetische Produkte. Als innovativer „owner-operator” beteiligt sich und unterstützt LIAN die…
LIAN Group renforce sa plateforme de santé avec l’acquisition stratégique de Scientis, la solution n°1 recommandée par les dermatologues pour l’hyperpigmentation
GENÈVE, 28 août 2024 /PRNewswire/ — Dans le cadre de sa plateforme d’investissement dans le secteur de la santé, LIAN Group, reconnu pour son modèle owner-operator, annonce l’acquisition de Scientis, une entreprise suisse de cosméceutiques à la pointe de l’innovation. Cette acquisition…
LIAN Group Expands Healthcare Platform with Strategic Acquisition of Scientis, #1 Dermatologist-Recommended Solution for Hyperpigmentation
GENEVA, Aug. 28, 2024 /PRNewswire/ — As part of its Healthcare investment platform, LIAN Group, an innovative owner- operator, announces the acquisition of Scientis, a pioneering Swiss Cosmeceutical company. This acquisition strengthens and expands LIAN’s growing footprint in the…
LIAN Group Expands Healthcare Platform with Strategic Acquisition of Scientis, #1 Dermatologist-Recommended Solution for Hyperpigmentation
GENEVA, Aug. 28, 2024 /PRNewswire/ — As part of its Healthcare investment platform, LIAN Group, an innovative owner- operator, announces the acquisition of Scientis, a pioneering Swiss Cosmeceutical company. This acquisition strengthens and expands LIAN’s growing footprint in the…
MPCC Q2 2024 Results: Backlog Increased to USD 1.1 Billion Creating Significant Earnings Visibility
OSLO, Norway, Aug. 28, 2024 /PRNewswire/ — MPC Container Ships (“MPCC” or the “Company”) delivered another quarter of solid operational and financial results, supported by efficient operations and continued high fleet utilization. During the quarter, MPCC was able to capitalize on…
